Certified by Founder Lodge
Dreavent
United States - Cambridge, Massachusetts
INVESTOR
1 Disclosed Funding Rounds $6,000,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Dreavent is an investment firm focused on Biotech Therapeutics companies. Our strategic location in the preeminent biotech hub, combined with a worldwide network of investors and partners, al
| Company | Date | Round | Raised |
|---|---|---|---|
Astrocyte Pharmaceuticals |
August, 22 ,2023 | Pre-Series B | $6,000,000 |
Astrocyte Pharmaceuticals
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
PowerLattice | $25,000,000 | (Nov 18, 2025)
Tribe Stays | $2,800,000 | (Nov 18, 2025)
Span(US) | $25,000,000 | (Nov 18, 2025)
AlertD | $3,000,000 | (Nov 18, 2025)
No Barrier Medical Translation | $2,700,000 | (Nov 18, 2025)